-
公开(公告)号:US20130225581A1
公开(公告)日:2013-08-29
申请号:US13810568
申请日:2011-07-15
IPC分类号: C07D495/04 , C07D401/14 , C07D413/14 , C07D401/12
CPC分类号: C07D495/04 , C07D401/12 , C07D401/14 , C07D413/14 , C07D417/14
摘要: The present invention provides a nitrogen-containing aromatic heterocyclic derivative represented by formula (I): [wherein W represents CR3 (wherein R3 represents a hydrogen atom or the like) or the like, R4 represents a hydrogen atom or the like, R5 represents a hydrogen atom or the like, R9 represents substituted imidazolyl, R12 and R13 may be the same or different, each represent a hydrogen atom or the like, R22 and R23 may be the same or different, each represent a hydrogen atom or the like, R24 represents a hydrogen atom or the like, Y represents C—R25 (wherein R25 represents a hydrogen atom or the like) or the like] or a pharmaceutically acceptable salt thereof and a FGFR inhibitor comprising, as an active ingredient, the nitrogen-containing aromatic heterocyclic derivative or the pharmaceutically acceptable salt thereof, or the like.
摘要翻译: 本发明提供式(I)表示的含氮芳香族杂环衍生物:[式中,W表示CR 3(式中,R 3表示氢原子等)等,R 4表示氢原子等,R 5表示 氢原子等,R 9表示取代的咪唑基,R 12和R 13可以相同或不同,各自表示氢原子等,R 22和R 23可以相同或不同,分别表示氢原子等,R 24 表示氢原子等,Y表示C-R25(其中R25表示氢原子等)等或其药学上可接受的盐和FGFR抑制剂,作为活性成分,含氮芳香族 杂环衍生物或其药学上可接受的盐等。